![Mark Hensley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Hensley
Président chez
CALLIDITAS THERAPEUTICS AB
Fortune : 118 990 $ au 31/05/2026
Profil
Mark E.
Hensley currently works at Calliditas Therapeutics AB, as Chairman and Heron Therapeutics, Inc., as Chief Operating Officer from 2025.
Mr. Hensley also formerly worked at Veloxis Pharmaceuticals A, as Chief Commercial Officer from 2018 to 2021.
Mr. Hensley received his undergraduate degree from the University of North Texas.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/05/2026 | 136 770 ( 0,07% ) | 118 990 $ | 31/05/2026 |
Postes actifs de Mark Hensley
| Sociétés | Poste | Début |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Président | - |
| HERON THERAPEUTICS, INC. | Directeur des opérations | 28/04/2025 |
Anciens postes connus de Mark Hensley
| Sociétés | Poste | Fin |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 01/01/2021 |
Formation de Mark Hensley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
University of North Texas
 University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
